Global Bifidobacteria Probiotic Market Growth 2022-2028
The global market for Bifidobacteria Probiotic is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Bifidobacteria Probiotic market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Bifidobacteria Probiotic market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Bifidobacteria Probiotic market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Bifidobacteria Probiotic market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Bifidobacteria Probiotic players cover Chr. Hansen Holding A/S, BioGaia AB, Probi AB, DowDuPont Inc. and Nestlé S.A., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Bifidobacteria Probiotic market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Bifidobacteria Probiotic market, with both quantitative and qualitative data, to help readers understand how the Bifidobacteria Probiotic market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Bifidobacteria Probiotic market and forecasts the market size by Type (Dry and Liquid,), by Application (Hypermarket/Supermarket, Medical Stores, Specialty Stores and Online Stores), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Dry
Liquid
Segmentation by application
Hypermarket/Supermarket
Medical Stores
Specialty Stores
Online Stores
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Chr. Hansen Holding A/S
BioGaia AB
Probi AB
DowDuPont Inc.
Nestlé S.A.
Procter & Gamble Company
Probiotics International Limite
Lallemand Inc
PharmaCare Laboratories
Dr. Willmar Schwabe Group
SymbioPharm GmbH
Pfizer
Incal Health
Chapter Introduction
Chapter 1: Scope of Bifidobacteria Probiotic, Research Methodology, etc.
Chapter 2: Executive Summary, global Bifidobacteria Probiotic market size (sales and revenue) and CAGR, Bifidobacteria Probiotic market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Bifidobacteria Probiotic sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Bifidobacteria Probiotic sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Bifidobacteria Probiotic market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Chr. Hansen Holding A/S, BioGaia AB, Probi AB, DowDuPont Inc., Nestlé S.A., Procter & Gamble Company, Probiotics International Limite, Lallemand Inc and PharmaCare Laboratories, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bifidobacteria Probiotic Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Bifidobacteria Probiotic by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Bifidobacteria Probiotic by Country/Region, 2017, 2022 & 2028
2.2 Bifidobacteria Probiotic Segment by Type
2.2.1 Dry
2.2.2 Liquid
2.3 Bifidobacteria Probiotic Sales by Type
2.3.1 Global Bifidobacteria Probiotic Sales Market Share by Type (2017-2022)
2.3.2 Global Bifidobacteria Probiotic Revenue and Market Share by Type (2017-2022)
2.3.3 Global Bifidobacteria Probiotic Sale Price by Type (2017-2022)
2.4 Bifidobacteria Probiotic Segment by Application
2.4.1 Hypermarket/Supermarket
2.4.2 Medical Stores
2.4.3 Specialty Stores
2.4.4 Online Stores
2.5 Bifidobacteria Probiotic Sales by Application
2.5.1 Global Bifidobacteria Probiotic Sale Market Share by Application (2017-2022)
2.5.2 Global Bifidobacteria Probiotic Revenue and Market Share by Application (2017-2022)
2.5.3 Global Bifidobacteria Probiotic Sale Price by Application (2017-2022)
3 Global Bifidobacteria Probiotic by Company
3.1 Global Bifidobacteria Probiotic Breakdown Data by Company
3.1.1 Global Bifidobacteria Probiotic Annual Sales by Company (2020-2022)
3.1.2 Global Bifidobacteria Probiotic Sales Market Share by Company (2020-2022)
3.2 Global Bifidobacteria Probiotic Annual Revenue by Company (2020-2022)
3.2.1 Global Bifidobacteria Probiotic Revenue by Company (2020-2022)
3.2.2 Global Bifidobacteria Probiotic Revenue Market Share by Company (2020-2022)
3.3 Global Bifidobacteria Probiotic Sale Price by Company
3.4 Key Manufacturers Bifidobacteria Probiotic Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bifidobacteria Probiotic Product Location Distribution
3.4.2 Players Bifidobacteria Probiotic Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Bifidobacteria Probiotic by Geographic Region
4.1 World Historic Bifidobacteria Probiotic Market Size by Geographic Region (2017-2022)
4.1.1 Global Bifidobacteria Probiotic Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Bifidobacteria Probiotic Annual Revenue by Geographic Region
4.2 World Historic Bifidobacteria Probiotic Market Size by Country/Region (2017-2022)
4.2.1 Global Bifidobacteria Probiotic Annual Sales by Country/Region (2017-2022)
4.2.2 Global Bifidobacteria Probiotic Annual Revenue by Country/Region
4.3 Americas Bifidobacteria Probiotic Sales Growth
4.4 APAC Bifidobacteria Probiotic Sales Growth
4.5 Europe Bifidobacteria Probiotic Sales Growth
4.6 Middle East & Africa Bifidobacteria Probiotic Sales Growth
5 Americas
5.1 Americas Bifidobacteria Probiotic Sales by Country
5.1.1 Americas Bifidobacteria Probiotic Sales by Country (2017-2022)
5.1.2 Americas Bifidobacteria Probiotic Revenue by Country (2017-2022)
5.2 Americas Bifidobacteria Probiotic Sales by Type
5.3 Americas Bifidobacteria Probiotic Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bifidobacteria Probiotic Sales by Region
6.1.1 APAC Bifidobacteria Probiotic Sales by Region (2017-2022)
6.1.2 APAC Bifidobacteria Probiotic Revenue by Region (2017-2022)
6.2 APAC Bifidobacteria Probiotic Sales by Type
6.3 APAC Bifidobacteria Probiotic Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bifidobacteria Probiotic by Country
7.1.1 Europe Bifidobacteria Probiotic Sales by Country (2017-2022)
7.1.2 Europe Bifidobacteria Probiotic Revenue by Country (2017-2022)
7.2 Europe Bifidobacteria Probiotic Sales by Type
7.3 Europe Bifidobacteria Probiotic Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bifidobacteria Probiotic by Country
8.1.1 Middle East & Africa Bifidobacteria Probiotic Sales by Country (2017-2022)
8.1.2 Middle East & Africa Bifidobacteria Probiotic Revenue by Country (2017-2022)
8.2 Middle East & Africa Bifidobacteria Probiotic Sales by Type
8.3 Middle East & Africa Bifidobacteria Probiotic Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bifidobacteria Probiotic
10.3 Manufacturing Process Analysis of Bifidobacteria Probiotic
10.4 Industry Chain Structure of Bifidobacteria Probiotic
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bifidobacteria Probiotic Distributors
11.3 Bifidobacteria Probiotic Customer
12 World Forecast Review for Bifidobacteria Probiotic by Geographic Region
12.1 Global Bifidobacteria Probiotic Market Size Forecast by Region
12.1.1 Global Bifidobacteria Probiotic Forecast by Region (2023-2028)
12.1.2 Global Bifidobacteria Probiotic Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bifidobacteria Probiotic Forecast by Type
12.7 Global Bifidobacteria Probiotic Forecast by Application
13 Key Players Analysis
13.1 Chr. Hansen Holding A/S
13.1.1 Chr. Hansen Holding A/S Company Information
13.1.2 Chr. Hansen Holding A/S Bifidobacteria Probiotic Product Offered
13.1.3 Chr. Hansen Holding A/S Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Chr. Hansen Holding A/S Main Business Overview
13.1.5 Chr. Hansen Holding A/S Latest Developments
13.2 BioGaia AB
13.2.1 BioGaia AB Company Information
13.2.2 BioGaia AB Bifidobacteria Probiotic Product Offered
13.2.3 BioGaia AB Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 BioGaia AB Main Business Overview
13.2.5 BioGaia AB Latest Developments
13.3 Probi AB
13.3.1 Probi AB Company Information
13.3.2 Probi AB Bifidobacteria Probiotic Product Offered
13.3.3 Probi AB Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Probi AB Main Business Overview
13.3.5 Probi AB Latest Developments
13.4 DowDuPont Inc.
13.4.1 DowDuPont Inc. Company Information
13.4.2 DowDuPont Inc. Bifidobacteria Probiotic Product Offered
13.4.3 DowDuPont Inc. Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 DowDuPont Inc. Main Business Overview
13.4.5 DowDuPont Inc. Latest Developments
13.5 Nestlé S.A.
13.5.1 Nestlé S.A. Company Information
13.5.2 Nestlé S.A. Bifidobacteria Probiotic Product Offered
13.5.3 Nestlé S.A. Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Nestlé S.A. Main Business Overview
13.5.5 Nestlé S.A. Latest Developments
13.6 Procter & Gamble Company
13.6.1 Procter & Gamble Company Company Information
13.6.2 Procter & Gamble Company Bifidobacteria Probiotic Product Offered
13.6.3 Procter & Gamble Company Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Procter & Gamble Company Main Business Overview
13.6.5 Procter & Gamble Company Latest Developments
13.7 Probiotics International Limite
13.7.1 Probiotics International Limite Company Information
13.7.2 Probiotics International Limite Bifidobacteria Probiotic Product Offered
13.7.3 Probiotics International Limite Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Probiotics International Limite Main Business Overview
13.7.5 Probiotics International Limite Latest Developments
13.8 Lallemand Inc
13.8.1 Lallemand Inc Company Information
13.8.2 Lallemand Inc Bifidobacteria Probiotic Product Offered
13.8.3 Lallemand Inc Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Lallemand Inc Main Business Overview
13.8.5 Lallemand Inc Latest Developments
13.9 PharmaCare Laboratories
13.9.1 PharmaCare Laboratories Company Information
13.9.2 PharmaCare Laboratories Bifidobacteria Probiotic Product Offered
13.9.3 PharmaCare Laboratories Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 PharmaCare Laboratories Main Business Overview
13.9.5 PharmaCare Laboratories Latest Developments
13.10 Dr. Willmar Schwabe Group
13.10.1 Dr. Willmar Schwabe Group Company Information
13.10.2 Dr. Willmar Schwabe Group Bifidobacteria Probiotic Product Offered
13.10.3 Dr. Willmar Schwabe Group Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Dr. Willmar Schwabe Group Main Business Overview
13.10.5 Dr. Willmar Schwabe Group Latest Developments
13.11 SymbioPharm GmbH
13.11.1 SymbioPharm GmbH Company Information
13.11.2 SymbioPharm GmbH Bifidobacteria Probiotic Product Offered
13.11.3 SymbioPharm GmbH Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 SymbioPharm GmbH Main Business Overview
13.11.5 SymbioPharm GmbH Latest Developments
13.12 Pfizer
13.12.1 Pfizer Company Information
13.12.2 Pfizer Bifidobacteria Probiotic Product Offered
13.12.3 Pfizer Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Pfizer Main Business Overview
13.12.5 Pfizer Latest Developments
13.13 Incal Health
13.13.1 Incal Health Company Information
13.13.2 Incal Health Bifidobacteria Probiotic Product Offered
13.13.3 Incal Health Bifidobacteria Probiotic Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Incal Health Main Business Overview
13.13.5 Incal Health Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Bifidobacteria Probiotic Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Bifidobacteria Probiotic Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Dry
Table 4. Major Players of Liquid
Table 5. Global Bifidobacteria Probiotic Sales by Type (2017-2022) & (K Units)
Table 6. Global Bifidobacteria Probiotic Sales Market Share by Type (2017-2022)
Table 7. Global Bifidobacteria Probiotic Revenue by Type (2017-2022) & ($ million)
Table 8. Global Bifidobacteria Probiotic Revenue Market Share by Type (2017-2022)
Table 9. Global Bifidobacteria Probiotic Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Bifidobacteria Probiotic Sales by Application (2017-2022) & (K Units)
Table 11. Global Bifidobacteria Probiotic Sales Market Share by Application (2017-2022)
Table 12. Global Bifidobacteria Probiotic Revenue by Application (2017-2022)
Table 13. Global Bifidobacteria Probiotic Revenue Market Share by Application (2017-2022)
Table 14. Global Bifidobacteria Probiotic Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Bifidobacteria Probiotic Sales by Company (2020-2022) & (K Units)
Table 16. Global Bifidobacteria Probiotic Sales Market Share by Company (2020-2022)
Table 17. Global Bifidobacteria Probiotic Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Bifidobacteria Probiotic Revenue Market Share by Company (2020-2022)
Table 19. Global Bifidobacteria Probiotic Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Bifidobacteria Probiotic Producing Area Distribution and Sales Area
Table 21. Players Bifidobacteria Probiotic Products Offered
Table 22. Bifidobacteria Probiotic Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Bifidobacteria Probiotic Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Bifidobacteria Probiotic Sales Market Share Geographic Region (2017-2022)
Table 27. Global Bifidobacteria Probiotic Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Bifidobacteria Probiotic Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Bifidobacteria Probiotic Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Bifidobacteria Probiotic Sales Market Share by Country/Region (2017-2022)
Table 31. Global Bifidobacteria Probiotic Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Bifidobacteria Probiotic Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Bifidobacteria Probiotic Sales by Country (2017-2022) & (K Units)
Table 34. Americas Bifidobacteria Probiotic Sales Market Share by Country (2017-2022)
Table 35. Americas Bifidobacteria Probiotic Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Bifidobacteria Probiotic Revenue Market Share by Country (2017-2022)
Table 37. Americas Bifidobacteria Probiotic Sales by Type (2017-2022) & (K Units)
Table 38. Americas Bifidobacteria Probiotic Sales Market Share by Type (2017-2022)
Table 39. Americas Bifidobacteria Probiotic Sales by Application (2017-2022) & (K Units)
Table 40. Americas Bifidobacteria Probiotic Sales Market Share by Application (2017-2022)
Table 41. APAC Bifidobacteria Probiotic Sales by Region (2017-2022) & (K Units)
Table 42. APAC Bifidobacteria Probiotic Sales Market Share by Region (2017-2022)
Table 43. APAC Bifidobacteria Probiotic Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Bifidobacteria Probiotic Revenue Market Share by Region (2017-2022)
Table 45. APAC Bifidobacteria Probiotic Sales by Type (2017-2022) & (K Units)
Table 46. APAC Bifidobacteria Probiotic Sales Market Share by Type (2017-2022)
Table 47. APAC Bifidobacteria Probiotic Sales by Application (2017-2022) & (K Units)
Table 48. APAC Bifidobacteria Probiotic Sales Market Share by Application (2017-2022)
Table 49. Europe Bifidobacteria Probiotic Sales by Country (2017-2022) & (K Units)
Table 50. Europe Bifidobacteria Probiotic Sales Market Share by Country (2017-2022)
Table 51. Europe Bifidobacteria Probiotic Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Bifidobacteria Probiotic Revenue Market Share by Country (2017-2022)
Table 53. Europe Bifidobacteria Probiotic Sales by Type (2017-2022) & (K Units)
Table 54. Europe Bifidobacteria Probiotic Sales Market Share by Type (2017-2022)
Table 55. Europe Bifidobacteria Probiotic Sales by Application (2017-2022) & (K Units)
Table 56. Europe Bifidobacteria Probiotic Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Bifidobacteria Probiotic Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Bifidobacteria Probiotic Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Bifidobacteria Probiotic Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Bifidobacteria Probiotic Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Bifidobacteria Probiotic Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Bifidobacteria Probiotic Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Bifidobacteria Probiotic Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Bifidobacteria Probiotic Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Bifidobacteria Probiotic
Table 66. Key Market Challenges & Risks of Bifidobacteria Probiotic
Table 67. Key Industry Trends of Bifidobacteria Probiotic
Table 68. Bifidobacteria Probiotic Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Bifidobacteria Probiotic Distributors List
Table 71. Bifidobacteria Probiotic Customer List
Table 72. Global Bifidobacteria Probiotic Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Bifidobacteria Probiotic Sales Market Forecast by Region
Table 74. Global Bifidobacteria Probiotic Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Bifidobacteria Probiotic Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Bifidobacteria Probiotic Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Bifidobacteria Probiotic Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Bifidobacteria Probiotic Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Bifidobacteria Probiotic Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Bifidobacteria Probiotic Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Bifidobacteria Probiotic Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Bifidobacteria Probiotic Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Bifidobacteria Probiotic Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Bifidobacteria Probiotic Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Bifidobacteria Probiotic Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Bifidobacteria Probiotic Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Bifidobacteria Probiotic Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Bifidobacteria Probiotic Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Bifidobacteria Probiotic Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Bifidobacteria Probiotic Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Bifidobacteria Probiotic Revenue Market Share Forecast by Application (2023-2028)
Table 92. Chr. Hansen Holding A/S Basic Information, Bifidobacteria Probiotic Manufacturing Base, Sales Area and Its Competitors
Table 93. Chr. Hansen Holding A/S Bifidobacteria Probiotic Product Offered
Table 94. Chr. Hansen Holding A/S Bifidobacteria Probiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Chr. Hansen Holding A/S Main Business
Table 96. Chr. Hansen Holding A/S Latest Developments
Table 97. BioGaia AB Basic Information, Bifidobacteria Probiotic Manufacturing Base, Sales Area and Its Competitors
Table 98. BioGaia AB Bifidobacteria Probiotic Product Offered
Table 99. BioGaia AB Bifidobacteria Probiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. BioGaia AB Main Business
Table 101. BioGaia AB Latest Developments
Table 102. Probi AB Basic Information, Bifidobacteria Probiotic Manufacturing Base, Sales Area and Its Competitors
Table 103. Probi AB Bifidobacteria Probiotic Product Offered
Table 104. Probi AB Bifidobacteria Probiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Probi AB Main Business
Table 106. Probi AB Latest Developments
Table 107. DowDuPont Inc. Basic Information, Bifidobacteria Probiotic Manufacturing Base, Sales Area and Its Competitors
Table 108. DowDuPont Inc. Bifidobacteria Probiotic Product Offered
Table 109. DowDuPont Inc. Bifidobacteria Probiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. DowDuPont Inc. Main Business
Table 111. DowDuPont Inc. Latest Developments
Table 112. Nestlé S.A. Basic Information, Bifidobacteria Probiotic Manufacturing Base, Sales Area and Its Competitors
Table 113. Nestlé S.A. Bifidobacteria Probiotic Product Offered
Table 114. Nestlé S.A. Bifidobacteria Probiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Nestlé S.A. Main Business
Table 116. Nestlé S.A. Latest Developments
Table 117. Procter & Gamble Company Basic Information, Bifidobacteria Probiotic Manufacturing Base, Sales Area and Its Competitors
Table 118. Procter & Gamble Company Bifidobacteria Probiotic Product Offered
Table 119. Procter & Gamble Company Bifidobacteria Probiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Procter & Gamble Company Main Business
Table 121. Procter & Gamble Company Latest Developments
Table 122. Probiotics International Limite Basic Information, Bifidobacteria Probiotic Manufacturing Base, Sales Area and Its Competitors
Table 123. Probiotics International Limite Bifidobacteria Probiotic Product Offered
Table 124. Probiotics International Limite Bifidobacteria Probiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Probiotics International Limite Main Business
Table 126. Probiotics International Limite Latest Developments
Table 127. Lallemand Inc Basic Information, Bifidobacteria Probiotic Manufacturing Base, Sales Area and Its Competitors
Table 128. Lallemand Inc Bifidobacteria Probiotic Product Offered
Table 129. Lallemand Inc Bifidobacteria Probiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Lallemand Inc Main Business
Table 131. Lallemand Inc Latest Developments
Table 132. PharmaCare Laboratories Basic Information, Bifidobacteria Probiotic Manufacturing Base, Sales Area and Its Competitors
Table 133. PharmaCare Laboratories Bifidobacteria Probiotic Product Offered
Table 134. PharmaCare Laboratories Bifidobacteria Probiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. PharmaCare Laboratories Main Business
Table 136. PharmaCare Laboratories Latest Developments
Table 137. Dr. Willmar Schwabe Group Basic Information, Bifidobacteria Probiotic Manufacturing Base, Sales Area and Its Competitors
Table 138. Dr. Willmar Schwabe Group Bifidobacteria Probiotic Product Offered
Table 139. Dr. Willmar Schwabe Group Bifidobacteria Probiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Dr. Willmar Schwabe Group Main Business
Table 141. Dr. Willmar Schwabe Group Latest Developments
Table 142. SymbioPharm GmbH Basic Information, Bifidobacteria Probiotic Manufacturing Base, Sales Area and Its Competitors
Table 143. SymbioPharm GmbH Bifidobacteria Probiotic Product Offered
Table 144. SymbioPharm GmbH Bifidobacteria Probiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. SymbioPharm GmbH Main Business
Table 146. SymbioPharm GmbH Latest Developments
Table 147. Pfizer Basic Information, Bifidobacteria Probiotic Manufacturing Base, Sales Area and Its Competitors
Table 148. Pfizer Bifidobacteria Probiotic Product Offered
Table 149. Pfizer Bifidobacteria Probiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Pfizer Main Business
Table 151. Pfizer Latest Developments
Table 152. Incal Health Basic Information, Bifidobacteria Probiotic Manufacturing Base, Sales Area and Its Competitors
Table 153. Incal Health Bifidobacteria Probiotic Product Offered
Table 154. Incal Health Bifidobacteria Probiotic Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Incal Health Main Business
Table 156. Incal Health Latest Developments
List of Figures
Figure 1. Picture of Bifidobacteria Probiotic
Figure 2. Bifidobacteria Probiotic Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bifidobacteria Probiotic Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Bifidobacteria Probiotic Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Bifidobacteria Probiotic Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Dry
Figure 10. Product Picture of Liquid
Figure 11. Global Bifidobacteria Probiotic Sales Market Share by Type in 2021
Figure 12. Global Bifidobacteria Probiotic Revenue Market Share by Type (2017-2022)
Figure 13. Bifidobacteria Probiotic Consumed in Hypermarket/Supermarket
Figure 14. Global Bifidobacteria Probiotic Market: Hypermarket/Supermarket (2017-2022) & (K Units)
Figure 15. Bifidobacteria Probiotic Consumed in Medical Stores
Figure 16. Global Bifidobacteria Probiotic Market: Medical Stores (2017-2022) & (K Units)
Figure 17. Bifidobacteria Probiotic Consumed in Specialty Stores
Figure 18. Global Bifidobacteria Probiotic Market: Specialty Stores (2017-2022) & (K Units)
Figure 19. Bifidobacteria Probiotic Consumed in Online Stores
Figure 20. Global Bifidobacteria Probiotic Market: Online Stores (2017-2022) & (K Units)
Figure 21. Global Bifidobacteria Probiotic Sales Market Share by Application (2017-2022)
Figure 22. Global Bifidobacteria Probiotic Revenue Market Share by Application in 2021
Figure 23. Bifidobacteria Probiotic Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Bifidobacteria Probiotic Revenue Market Share by Company in 2021
Figure 25. Global Bifidobacteria Probiotic Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Bifidobacteria Probiotic Revenue Market Share by Geographic Region in 2021
Figure 27. Global Bifidobacteria Probiotic Sales Market Share by Region (2017-2022)
Figure 28. Global Bifidobacteria Probiotic Revenue Market Share by Country/Region in 2021
Figure 29. Americas Bifidobacteria Probiotic Sales 2017-2022 (K Units)
Figure 30. Americas Bifidobacteria Probiotic Revenue 2017-2022 ($ Millions)
Figure 31. APAC Bifidobacteria Probiotic Sales 2017-2022 (K Units)
Figure 32. APAC Bifidobacteria Probiotic Revenue 2017-2022 ($ Millions)
Figure 33. Europe Bifidobacteria Probiotic Sales 2017-2022 (K Units)
Figure 34. Europe Bifidobacteria Probiotic Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Bifidobacteria Probiotic Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Bifidobacteria Probiotic Revenue 2017-2022 ($ Millions)
Figure 37. Americas Bifidobacteria Probiotic Sales Market Share by Country in 2021
Figure 38. Americas Bifidobacteria Probiotic Revenue Market Share by Country in 2021
Figure 39. United States Bifidobacteria Probiotic Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Bifidobacteria Probiotic Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Bifidobacteria Probiotic Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Bifidobacteria Probiotic Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Bifidobacteria Probiotic Sales Market Share by Region in 2021
Figure 44. APAC Bifidobacteria Probiotic Revenue Market Share by Regions in 2021
Figure 45. China Bifidobacteria Probiotic Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Bifidobacteria Probiotic Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Bifidobacteria Probiotic Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Bifidobacteria Probiotic Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Bifidobacteria Probiotic Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Bifidobacteria Probiotic Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Bifidobacteria Probiotic Sales Market Share by Country in 2021
Figure 52. Europe Bifidobacteria Probiotic Revenue Market Share by Country in 2021
Figure 53. Germany Bifidobacteria Probiotic Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Bifidobacteria Probiotic Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Bifidobacteria Probiotic Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Bifidobacteria Probiotic Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Bifidobacteria Probiotic Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Bifidobacteria Probiotic Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Bifidobacteria Probiotic Revenue Market Share by Country in 2021
Figure 60. Egypt Bifidobacteria Probiotic Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Bifidobacteria Probiotic Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Bifidobacteria Probiotic Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Bifidobacteria Probiotic Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Bifidobacteria Probiotic Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Bifidobacteria Probiotic in 2021
Figure 66. Manufacturing Process Analysis of Bifidobacteria Probiotic
Figure 67. Industry Chain Structure of Bifidobacteria Probiotic
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets